Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@AppleHelix Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::98707539.png) @AppleHelix Jing Liang πŸ‡ΊπŸ‡¦

Jing Liang πŸ‡ΊπŸ‡¦ posts on X about $prax, $mtsr, $trml, novartis the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

### Engagements: XXXXX [#](/creator/twitter::98707539/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::98707539/c:line/m:interactions.svg)

- X Week XXXXXX -XX%
- X Month XXXXXX -XX%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XXXX%

### Mentions: XX [#](/creator/twitter::98707539/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::98707539/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX +39%
- X Months XXX +15%
- X Year XXX +14%

### Followers: XXXXXX [#](/creator/twitter::98707539/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::98707539/c:line/m:followers.svg)

- X Week XXXXXX +0.44%
- X Month XXXXXX +1.20%
- X Months XXXXXX +8.40%
- X Year XXXXXX +18%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::98707539/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::98707539/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::98707539/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [finance](/list/finance)  XXXX%

**Social topic influence**
[$prax](/topic/$prax) #13, [$mtsr](/topic/$mtsr) 0.61%, [$trml](/topic/$trml) 0.61%, [novartis](/topic/novartis) 0.61%, [$entb](/topic/$entb) 0.61%, [dd](/topic/dd) 0.61%, [boston](/topic/boston) 0.61%, [mega](/topic/mega) 0.61%, [10m](/topic/10m) 0.61%, [bless](/topic/bless) XXXX%

**Top accounts mentioned or mentioned by**
[@jacobplieth](/creator/undefined) [@biopharmiq](/creator/undefined) [@sportsbios](/creator/undefined) [@andybiotech](/creator/undefined) [@sharkbiotech](/creator/undefined) [@houndcl](/creator/undefined) [@amaymd](/creator/undefined) [@ny1972_47](/creator/undefined) [@sanctuary_bio](/creator/undefined) [@jq1234t](/creator/undefined) [@bllphd](/creator/undefined) [@daphnezohar](/creator/undefined) [@lipa0902](/creator/undefined) [@bertrandbio](/creator/undefined) [@thebiohunter](/creator/undefined) [@realrambogotier](/creator/undefined) [@learnbiotech](/creator/undefined) [@mdurgin1](/creator/undefined) [@ny197247](/creator/undefined) [@sensiblemed](/creator/undefined)

**Top assets mentioned**
[Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Tourmaline Bio, Inc. Common Stock (TRML)](/topic/$trml) [Novartis AG (NVS)](/topic/novartis) [Novo-Nordisk (NVO)](/topic/$nvo) [WW International, Inc. Common Stock (WW)](/topic/$ww) [Eli Lilly and Company (LLY)](/topic/$lly)
### Top Social Posts [#](/creator/twitter::98707539/posts)
---
Top posts by engagements in the last XX hours

"1/ A few couple thoughts on $PRAX. - I love randomized withdrawal trials. Wish they are done more often. - FDA seems to bless these X studies as pivotal based on June 2023 PR - Pre-NDA request filed meaning $PRAX may get feedback by JP Morgan"  
[X Link](https://x.com/AppleHelix/status/1978789822069166479) [@AppleHelix](/creator/x/AppleHelix) 2025-10-16T11:47Z 10.1K followers, 27.1K engagements


"Recent Cardiometabolic M&As were all spinouts $TRML: HLE IL-6 from Pfizer $ENTB: pegylated FGF21 from Teva/Ratiopharma $MTSR: from DD Pharmatech Boston Pharma: from Novartis"  
[X Link](https://x.com/AppleHelix/status/1970136917238055123) [@AppleHelix](/creator/x/AppleHelix) 2025-09-22T14:43Z 10.1K followers, 6169 engagements


"Going public with a pipeline of X preclinical assets good luck"  
[X Link](https://x.com/AppleHelix/status/1974580672225591666) [@AppleHelix](/creator/x/AppleHelix) 2025-10-04T21:01Z 10.1K followers, 13.6K engagements


"5/ Clearly a sign of drug activity and a good commercial selling point :)"  
[X Link](https://x.com/AppleHelix/status/1978801056780894226) [@AppleHelix](/creator/x/AppleHelix) 2025-10-16T12:31Z 10.1K followers, 1787 engagements


"6/ 10m Americans have Essential Tremors. This could be a mega blockbuster"  
[X Link](https://x.com/AppleHelix/status/1978802219517673935) [@AppleHelix](/creator/x/AppleHelix) 2025-10-16T12:36Z 10.1K followers, XXX engagements


"Phase X CNS assets NDA ready that is small mol or biologics is scarce. It will get bought out. Now $PRAX will most likely raise after this. But it will be a good thing and oversubscribed. The post-money will boost takeout valuation even more"  
[X Link](https://x.com/AppleHelix/status/1978806698572665296) [@AppleHelix](/creator/x/AppleHelix) 2025-10-16T12:54Z 10.1K followers, 12.2K engagements


"Bertrand raises a very good point. Can one build a large European biotech without US investors Argenx and Ablynx come to mind. But they still had some US investors in the syndicate(s)"  
[X Link](https://x.com/AppleHelix/status/1947990259255373936) [@AppleHelix](/creator/x/AppleHelix) 2025-07-23T12:00Z 10.1K followers, 3640 engagements


"1/ This is a very interesting and creative deal by $BCRX acquiring $ATXS. Back of envelop math: - 56.4m $ATXS common shrs outstanding x $8.55/sh cash = $482m cash. There is also 5m pref shrs - BUT $ATXS has $250m cash on balance sheet at end of June"  
[X Link](https://x.com/AppleHelix/status/1978063324832022603) [@AppleHelix](/creator/x/AppleHelix) 2025-10-14T11:40Z 10.1K followers, 8507 engagements


"@houndcl @bigpharmaguy @TCellEngager @aditharun_ @sharkbiotech I think the rationale maybe the longer the duration the more dropouts. And the imputation of drop outs data at of trial will dilute efficacy"  
[X Link](https://x.com/AppleHelix/status/1978935881323925914) [@AppleHelix](/creator/x/AppleHelix) 2025-10-16T21:27Z 10.1K followers, XXX engagements


"It seems prescription Rx is going towards the DTC model bypassing PBMs (TrumpRx). If I were $NVO or $LLY I would consider buying $WW as a distribution channel"  
[X Link](https://x.com/AppleHelix/status/1978113648145883435) [@AppleHelix](/creator/x/AppleHelix) 2025-10-14T15:00Z 10.1K followers, 2929 engagements


"Must read article. H/T @jq1234t Imputation methodology is super important This is rarely discussed during clinical trial design"  
[X Link](https://x.com/AppleHelix/status/1979569451214438763) [@AppleHelix](/creator/x/AppleHelix) 2025-10-18T15:25Z 10.1K followers, 1365 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@AppleHelix Avatar @AppleHelix Jing Liang πŸ‡ΊπŸ‡¦

Jing Liang πŸ‡ΊπŸ‡¦ posts on X about $prax, $mtsr, $trml, novartis the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

  • X Week XXXXXX -XX%
  • X Month XXXXXX -XX%
  • X Months XXXXXXX -XX%
  • X Year XXXXXXXXX -XXXX%

Mentions: XX #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX +39%
  • X Months XXX +15%
  • X Year XXX +14%

Followers: XXXXXX #

Followers Line Chart

  • X Week XXXXXX +0.44%
  • X Month XXXXXX +1.20%
  • X Months XXXXXX +8.40%
  • X Year XXXXXX +18%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence stocks XXXX% finance XXXX%

Social topic influence $prax #13, $mtsr 0.61%, $trml 0.61%, novartis 0.61%, $entb 0.61%, dd 0.61%, boston 0.61%, mega 0.61%, 10m 0.61%, bless XXXX%

Top accounts mentioned or mentioned by @jacobplieth @biopharmiq @sportsbios @andybiotech @sharkbiotech @houndcl @amaymd @ny1972_47 @sanctuary_bio @jq1234t @bllphd @daphnezohar @lipa0902 @bertrandbio @thebiohunter @realrambogotier @learnbiotech @mdurgin1 @ny197247 @sensiblemed

Top assets mentioned Praxis Precision Medicines, Inc. Common Stock (PRAX) Metsera, Inc. Common Stock (MTSR) Tourmaline Bio, Inc. Common Stock (TRML) Novartis AG (NVS) Novo-Nordisk (NVO) WW International, Inc. Common Stock (WW) Eli Lilly and Company (LLY)

Top Social Posts #


Top posts by engagements in the last XX hours

"1/ A few couple thoughts on $PRAX. - I love randomized withdrawal trials. Wish they are done more often. - FDA seems to bless these X studies as pivotal based on June 2023 PR - Pre-NDA request filed meaning $PRAX may get feedback by JP Morgan"
X Link @AppleHelix 2025-10-16T11:47Z 10.1K followers, 27.1K engagements

"Recent Cardiometabolic M&As were all spinouts $TRML: HLE IL-6 from Pfizer $ENTB: pegylated FGF21 from Teva/Ratiopharma $MTSR: from DD Pharmatech Boston Pharma: from Novartis"
X Link @AppleHelix 2025-09-22T14:43Z 10.1K followers, 6169 engagements

"Going public with a pipeline of X preclinical assets good luck"
X Link @AppleHelix 2025-10-04T21:01Z 10.1K followers, 13.6K engagements

"5/ Clearly a sign of drug activity and a good commercial selling point :)"
X Link @AppleHelix 2025-10-16T12:31Z 10.1K followers, 1787 engagements

"6/ 10m Americans have Essential Tremors. This could be a mega blockbuster"
X Link @AppleHelix 2025-10-16T12:36Z 10.1K followers, XXX engagements

"Phase X CNS assets NDA ready that is small mol or biologics is scarce. It will get bought out. Now $PRAX will most likely raise after this. But it will be a good thing and oversubscribed. The post-money will boost takeout valuation even more"
X Link @AppleHelix 2025-10-16T12:54Z 10.1K followers, 12.2K engagements

"Bertrand raises a very good point. Can one build a large European biotech without US investors Argenx and Ablynx come to mind. But they still had some US investors in the syndicate(s)"
X Link @AppleHelix 2025-07-23T12:00Z 10.1K followers, 3640 engagements

"1/ This is a very interesting and creative deal by $BCRX acquiring $ATXS. Back of envelop math: - 56.4m $ATXS common shrs outstanding x $8.55/sh cash = $482m cash. There is also 5m pref shrs - BUT $ATXS has $250m cash on balance sheet at end of June"
X Link @AppleHelix 2025-10-14T11:40Z 10.1K followers, 8507 engagements

"@houndcl @bigpharmaguy @TCellEngager @aditharun_ @sharkbiotech I think the rationale maybe the longer the duration the more dropouts. And the imputation of drop outs data at of trial will dilute efficacy"
X Link @AppleHelix 2025-10-16T21:27Z 10.1K followers, XXX engagements

"It seems prescription Rx is going towards the DTC model bypassing PBMs (TrumpRx). If I were $NVO or $LLY I would consider buying $WW as a distribution channel"
X Link @AppleHelix 2025-10-14T15:00Z 10.1K followers, 2929 engagements

"Must read article. H/T @jq1234t Imputation methodology is super important This is rarely discussed during clinical trial design"
X Link @AppleHelix 2025-10-18T15:25Z 10.1K followers, 1365 engagements

creator/x::AppleHelix
/creator/x::AppleHelix